{"SPADE_UN_16379": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16379", "Peptide Name": "H-58, Hymenochirin-1B [P5K,E6K,D9K; S4,T7,N10-GlcNAc; A18,22 S5]", "Source": "Synthetic (Derived from Hymenochirin-1B)", "Family": "", "Gene": "Not found", "Sequence": "IKLXKKXKKXLKKVLKGXIKGXIAVAKMV", "Sequence Length": 29, "UniProt Entry": ["http://www.uniprot.org/uniprot/W8PRC4"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (IC50=0.62±0.12 μM); HCT 116 (IC50=1.29±0.08  μM); HepG2 (IC50=2.13±0.07 μM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C126H230N34O20S", "Mass": 362312, "PI": 11.75, "Net Charge": 10, "Hydrophobicity": 0.11, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B A Novel Glycosylated Staple Strategy", "Pubmed ID": "30789695", "Reference": "ACS Chem Biol. 2019 Mar 15;14(3)516-525.", "Author": "Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30789695"}], "Frequent Amino Acids": "KXI", "Absent Amino Acids": "CDEFHNOPQRSTUWY", "Basic Residues": 10, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 15, "Positive Residues": 10, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12558", "Similarity": 1.0, "Sequence": "KLKKLCCLLLLKKLKK"}, {"SPADE_ID": "SPADE_N_12582", "Similarity": 1.0, "Sequence": "KLKKCLCLLLLKKLKK"}, {"SPADE_ID": "SPADE_UN_20205", "Similarity": 1.0, "Sequence": "KLKKLCCLLLLKKLKK"}]}}}